PFM Health Sciences, LP

Q4 2017 13F Holdings Report, Stock Holdings

Signature - Title
Darren Mooney - Chief Compliance Officer
Location
San Francisco, CA
Holdings as of
December 31, 2017
Value $
$3.94B
Num holdings
74
Date filed
2/14/2018, 04:19 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2017 - Nov 14, 2017
Next filing
Q1 2018 - May 15, 2018
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2017 Q4 compared to 2017 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Darin Sadow General Counsel and Chief Compliance Officer San Francisco, California 2/5/2018